Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

More research is needed to understand sex and racial differences in long COVID.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

The editorial stresses the importance of COVID-19 vaccination and ongoing contributions to the journal.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Redefining drug dosages is crucial when repurposing them for new uses.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Long COVID patients have more health issues than non-infected people.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Microneedles are effective for drug delivery, vaccinations, fluid extraction, and treating hair loss, with advancements in manufacturing like 3D printing.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

Antibody treatments show promise for hair loss but need more research.